NEW YORK, Oct. 16, 2015 /PRNewswire/ -- Levi & Korsinsky, LLP announces that it has commenced an investigation of Imprivata, Inc. ("Imprivata" or the "Company") (NYSE: IMPR) concerning possible violations of federal securities laws by certain officers and directors.
On October 14, 2015, after the market closed, Imprivata issued a press release disclosing disappointing preliminary Third Quarter 2015 financial results. The Company further announced the unexpected delay of some Imprivata OneSign deals, which led to lower than expected revenue growth. The Company suggested that three factors contributed to the shortfall: the delay of certain large deals due to "customer implantation schedules and available IT resources," a decline in product sales due to several deals that failed to close, and lower than expected sales to smaller hospitals. Shares of Imprivata were down 33.55% on intraday trading on October 15, 2015. To obtain additional information about the investigation, go to:
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
SOURCE Levi & Korsinsky, LLP